APOLLOHOSP - Fundamental Analysis: Financial Health & Valuation
← Back to ListKey Parameters
⭐ Fundamental Rating: 3.2
Show all parameters (20 more)
🏭 Industry
The healthcare sector is generally characterized by high capital expenditure requirements, complex regulatory environments, and significant patient volume fluctuations, presenting both opportunities and challenges for financial stability. Hospitals typically operate with relatively low margins due to high fixed costs associated with infrastructure and personnel, making robust cash flow management paramount.
✅ Positive
The company demonstrates solid and consistent profitability with PAT of 385 Cr. in the latest quarter, only slightly up from the previous quarter, alongside a manageable debt-to-equity ratio of 0.32 indicating prudent capital management. Furthermore, the dividend yield provides some return for investors while the robust cash flows support shareholder returns.
⚠️ Limitation
The exceptionally high P/E ratio of 80.6 relative to the industry average of 49.6 suggests a significant premium valuation which raises concerns about overpaying for future growth or potential downside risk. While the company has strong profitability, margins are not exceptionally wide and could be vulnerable to competitive pressures; the PEG ratio of 8.53 further amplifies this valuation concern considering the current growth rate.
🧾 Long-Term Outlook
Based on the current data, a potential entry zone could be between 8,400 ₹ and 8,700 ₹, reflecting a modest discount to the prevailing price. A long-term holding strategy should focus on monitoring revenue growth (though it’s consistent, not exceptional) and maintaining the company's existing debt levels. Overall, while the high valuation warrants caution, APOLLOHOSP demonstrates reasonable financial health and operational stability within a generally defensive industry, making it a moderately attractive investment for patient capital over the long term.